Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, such as anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, anti–hypertensive, anti-malarial products, as well as vitamins, feed additives, xanthine derivatives and beverages, and phytochemicals, as well as provides intermediates. The company was founded in 1987 and is headquartered in Mumbai, India. The ISIN of this stock is INE07RO01027.